Light chain shuffling of a high affinity antibody results in a drift in epitope recognition

Molecular Immunology
M OhlinC A Borrebaeck

Abstract

Human polyclonal and monoclonal antibodies against pathogens and toxins are potentially useful in the treatment of various diseases. A number of human monoclonal antibodies with protective capacity in vitro have been established by conventional hybridoma technology. However, with the development of phage-display technology, the possibility of specifically tailoring antigen-binding properties has improved substantially. We show here that the reactivity of a high affinity, virus-neutralizing human antibody against the AD-2 epitope of cytomegalovirus gB can be modified by introducing other Vkappa sequences together with the original VH sequence. The fine specificity, as determined by the requirement of particular amino acid residues in the epitope, is shifted in these new antibody fragments. It was also evident that the VH/Vkappa pairing was not promiscuous, since antibody fragments selected by phage display retained light chain sequences very similar to the original hybridoma-derived light chain, proving that a high affinity interaction was very dependent on a co-operativity between both variable domains. These findings show that phage display technology might modify the binding properties of pre-existing, high affinity antibodies.

References

Jun 1, 1992·Scandinavian Journal of Immunology·A C MalmborgC A Borrebaeck
Aug 5, 1992·Journal of Molecular Biology·R E HawkinsG Winter
Apr 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·H GramA S Kang
May 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·C F BarbasR A Lerner
Nov 1, 1991·Journal of Clinical Microbiology·R LehnerM Mach
Nov 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·D R BurtonR A Lerner
Dec 5, 1991·Journal of Molecular Biology·J D MarksG Winter
Aug 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J S HustonR Crea
Nov 6, 1987·Science·H W SchroederR M Perlmutter
Dec 21, 1984·Nucleic Acids Research·M Pech, H G Zachau
Dec 1, 1994·The Journal of General Virology·R R SpaeteM P Landini
Jan 1, 1995·Immunology Today·B RapoportS M McLachlan
Aug 1, 1995·Nature Medicine·C F Barbas
May 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·R A WilliamsonD R Burton
Jan 1, 1995·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·E A PadlanJ P Tipper
Jan 1, 1993·Methods in Enzymology·H Potter
Apr 5, 1993·Journal of Molecular Biology·C F BarbasG R Pilkington

❮ Previous
Next ❯

Citations

Oct 30, 1996·Journal of Immunological Methods·A C MalmborgC A Borrebaeck
May 1, 1996·Molecular Immunology·M Ohlin, C A Borrebaeck
Apr 17, 2004·Journal of Immunological Methods·Ji Hee SonJeong Woo Park
Oct 8, 2003·Journal of Molecular Biology·Jorge SepúlvedaOscar R Burrone
Sep 11, 2002·Molecular Immunology·Peter EllmarkMats Ohlin
Aug 1, 2000·Immunology Today·H R Hoogenboom, P Chames
Aug 1, 2000·Immunology Today·C A Borrebaeck
Jun 6, 2000·Advanced Drug Delivery Reviews·H R Hoogenboom de Haard H
Aug 1, 1997·Current Opinion in Biotechnology·C Rader, C F Barbas
Apr 8, 1998·Immunotechnology : an International Journal of Immunological Engineering·H WatzkaD Moosmayer
Dec 16, 1998·Immunotechnology : an International Journal of Immunological Engineering·B L HallB J Kobrin
Mar 8, 2002·European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics·K Witzel-SchlömpP M Schneider
May 16, 2008·Protein Engineering, Design & Selection : PEDS·J RogersE C Tozer
Jun 18, 2011·Protein Engineering, Design & Selection : PEDS·E-C BrockmannU Lamminmäki
May 9, 2008·International Journal of Biological Sciences·Leili JiaQiao Li
Jul 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·C RaderC F Barbas
Mar 30, 2007·The Journal of Investigative Dermatology·Aimee S PayneJohn R Stanley
Aug 15, 2006·Journal of Molecular Biology·Ulrika AndréassonMats Ohlin
Mar 25, 2015·Molecular Immunology·Mats Ohlin, Cecilia Söderberg-Nauclér
Nov 14, 1997·Journal of Molecular Biology·A C MalmborgC A Borrebaeck
Jul 15, 2015·Chemical Communications : Chem Comm·Ruth LarragyAndrew Kellett
Aug 14, 2018·Biotechnology and Bioengineering·Tyler LopezXin Ge
Apr 8, 2010·Current Protocols in Neuroscience·Andrew R M Bradbury

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.